MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10428194.2025.2604300

Медицинская библиотека · Leukemia & lymphoma · 2026

Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).

Phillips Tycel, Zhou Ziqi, Gutierrez Cynthia, Shao Anran, Boyd Marley, Noshad Sina, Hohlbauch Andriana, Liu Nicholas, Repetny Karen, Fanale Michelle, Mitchell Betsy, Davis E Anne, Gennarelli Renee, Burke John M

СтатьяПеревод в очереди

Аннотация

To understand the recent, evolving treatment landscape for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), we retrospectively analyzed US claims data from MarketScan Commercial Claims and Encounters and Medicare databases and Symphony Health Solutions database for adult patients who initiated first-line DLBCL therapy from January 2017 through June 2023 (MarketScan) or May 2024 (Symphony). The MarketScan analysis included 3552 patients (median follow-up: 15 months). The Symphony analysis included 49,370 patients (median follow-up: 35 months). Results from this contemporary real-world analysis showed heterogeneity in DLBCL treatments administered, with a lack of standard of care in the third-line/fourth-line setting. In both analyses, most patients (>50% per line) received rituximab-based therapy as second-line or later-line therapy. These results highlight a need for new regimens that demonstrate clinical benefit and improve overall survival in patients with R/R DLBCL, while also being feasible and widely applicable in routine practice.

Для цитирования: Phillips Tycel, Zhou Ziqi, Gutierrez Cynthia, Shao Anran, Boyd Marley, Noshad Sina, Hohlbauch Andriana, Liu Nicholas, Repetny Karen, Fanale Michelle, Mitchell Betsy, Davis E Anne, Gennarelli Renee, Burke John M. Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).. Leukemia & lymphoma. 2026. DOI: 10.1080/10428194.2025.2604300.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.